Lichen Planopilaris and Frontal Fibrosing Alopecia: Correlation of Clinical and Dermoscopic Findings with the Degree of Inflammation in Histopathological Examination

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Methotrexate may help stabilize frontal fibrosing alopecia.

More inflammation leads to faster and worse hair loss in women with frontal fibrosing alopecia.

Oral minoxidil can increase or maintain hair thickness in most people with lichen planopilaris, with mild side effects.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Regular use of sunscreen may be linked to frontal fibrosing alopecia.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Contact allergies might contribute to frontal fibrosing alopecia.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Trichoscopy is a quick, noninvasive method to diagnose hair and scalp disorders, often reducing the need for biopsies.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Lack of small, fine hair on the front hairline is a key sign of frontal fibrosing alopecia.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Dermatoscopy is a useful tool for diagnosing hair disorders and can help choose samples for more detailed analysis.

The book helps doctors better understand and treat hair disorders due to gaps in their training.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

Dermatoscopy is useful for identifying different hair and scalp conditions and can reduce the need for biopsies.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

No treatment showed clear superiority for lichen planopilaris.

Trichoscopy can diagnose female hair loss with high accuracy by looking for specific patterns in hair and scalp appearance.

The article explains how to diagnose and manage certain types of scarring hair loss.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.

Lichen planopilaris may be linked to autoimmune thyroiditis.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

bFGF, VEGF, and minoxidil decrease collagen production in hair cells, possibly affecting hair growth.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.